Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM |
|---|---|
| Recipient Organization | West Chester University of Pennsylvania |
| Country | United States |
| Start Date | Sep 20, 2024 |
| End Date | Aug 31, 2027 |
| Duration | 1,075 days |
| Number of Grantees | 3 |
| Roles | Principal Investigator; Co-Investigator |
| Data Source | NIH (US) |
| Grant ID | 10875785 |
PROJECT SUMMARY: Alcohol and nicotine are the two most commonly consumed licit drugs among pregnant people. Although the potential consequences of prenatal alcohol exposure at different levels are well understood, the patterns of nicotine consumption have changed over the years with the popularity of electronic cigarettes (e-cigarettes). E-
cigarettes can increase a drug’s presence in blood levels more than traditional routes, which is particularly alarming given that alcohol and nicotine are commonly used together among pregnant people. However, the potential consequences of combined alcohol and nicotine exposure via e-cigarettes during early developmental
on brain and behavioral development are unclear. This project will use a mouse model to investigate whether co-exposure to these drugs during early development alters drug metabolism, shifts intestinal microbiome populations, changes gene expression, and/or modulates later-life behaviors. Dams and their neonates will be
exposed to alcohol, nicotine via e-cigarettes, the combination, or a control condition (vehicle or ambient air) during the brain growth spurt period using a novel co-exposure model that mimics the doses and delivery devices currently seen in human consumption. Aim 1 of this project will examine whether developmental co-exposure of
alcohol and nicotine via e-cigarettes increases blood levels of each drug, alters drug metabolism enzymes in the liver, increases serum triglyceride levels, and/or shifts the gut microbiota composition. Plasma will be collected from the dams to examine blood alcohol and nicotine concentrations during exposure. Additionally, plasma, fecal
and cecal matter, and liver tissue will be collected from both the dams and offspring to measure serum triglyceride concentrations (colorimetric assay), drug metabolism enzymes (western blot), and microbiota shifts (shotgun metagenomic sequencing and 16s rRNA sequencing) following acute (dams) and developmental (offspring)
exposure. Aim 2 of this project will determine whether developmental co-exposure to alcohol and nicotine via e- cigarettes alters motor- and anxiety-related behaviors and/or correlated gene expression in the associated brain regions. Later in life, sex pairs from each litter will be examined for motor- and anxiety-related behaviors using
open-field activity chambers, a forelimb reaching task, and an elevated plus maze. Critical motor- and anxiety- related brain regions of subjects will also be analyzed to examine gene expression alterations via reverse transcription quantitative real-time PCR (RT-qPCR). These data will provide valuable information regarding the
potential consequences of e-cigarette use among pregnant people, particularly when used in combination with alcohol. In addition to providing information for teratology research, these data will also be valuable to general research in substance use and pharmacology. Importantly, all data will be collected and analyzed by graduate
and undergraduate students in the Psychology, Biology, and Chemistry departments at West Chester University. This project will enable students in the project-associated labs to advance their research professional development and prepare them for future Ph.D. and medical school programs.
West Chester University of Pennsylvania
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant